Table 5 Usage of calcimimetics and intravenous VDRA(vitamin D receptor activator), 2019
From: Annual dialysis data report 2019, JSDT Renal Data Registry
Calcimimetics use | None | Maxacalcitol | Calcitriol | Subtotal | Unspecified | No information available | Total |
|---|---|---|---|---|---|---|---|
None | 128,905 | 41,655 | 15,535 | 186,095 | 118 | 440 | 186,653 |
(%) | (69.3) | (22.4) | (8.3) | (100.0) | |||
Cinacalcet | 7,047 | 4,974 | 1,537 | 13,558 | 7 | 339 | 13,904 |
(%) | (52.0) | (36.7) | (11.3) | (100.0) | |||
Etercalcetide | 9,667 | 15,346 | 5,664 | 30,677 | 16 | 449 | 31,142 |
(%) | (31.5) | (50.0) | (18.5) | (100.0) | |||
Evocalcet | 19,013 | 13,494 | 6,191 | 38,698 | 9 | 919 | 39,626 |
(%) | (49.1) | (34.9) | (16.0) | (100.0) | |||
Subtotal | 164,632 | 75,469 | 28,927 | 269,028 | 150 | 2,147 | 271,325 |
(%) | (61.2) | (28.1) | (10.8) | (100.0) | |||
Unspecified | 161 | 156 | 37 | 354 | 700 | 1 | 1,055 |
(%) | (45.5) | (44.1) | (10.5) | (100.0) | |||
No information available | 625 | 1,862 | 776 | 3,263 | 121 | 56,835 | 60,219 |
(%) | (19.2) | (57.1) | (23.8) | (100.0) | |||
Total | 1,65,418 | 77,487 | 29,740 | 2,72,645 | 971 | 58,983 | 332,599 |
(%) | (60.7) | (28.4) | (10.9) | (100.0) |